Cargando…

QuPath: Open source software for digital pathology image analysis

QuPath is new bioimage analysis software designed to meet the growing need for a user-friendly, extensible, open-source solution for digital pathology and whole slide image analysis. In addition to offering a comprehensive panel of tumor identification and high-throughput biomarker evaluation tools,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bankhead, Peter, Loughrey, Maurice B., Fernández, José A., Dombrowski, Yvonne, McArt, Darragh G., Dunne, Philip D., McQuaid, Stephen, Gray, Ronan T., Murray, Liam J., Coleman, Helen G., James, Jacqueline A., Salto-Tellez, Manuel, Hamilton, Peter W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715110/ https://www.ncbi.nlm.nih.gov/pubmed/29203879 http://dx.doi.org/10.1038/s41598-017-17204-5

Ejemplares similares

QuPath: The global impact of an open source digital pathology system
por: Humphries, M.P., et al.
Publicado: (2021)

QuPath Digital Immunohistochemical Analysis of Placental Tissue
por: Hein, Ashley L., et al.
Publicado: (2021)

A Straightforward Method for Adipocyte Size and Count Analysis Using Open-source Software QuPath
por: Palomäki, Ville A, et al.
Publicado: (2022)

cudaMap: a GPU accelerated program for gene expression connectivity mapping
por: McArt, Darragh G, et al.
Publicado: (2013)

QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray
por: Porter, Ross J., et al.
Publicado: (2023)

QuPath Automated Analysis of Optic Nerve Degeneration in Brown Norway Rats
por: Mysona, Barbara A., et al.
Publicado: (2020)

Whole-Slide Image Analysis of Human Pancreas Samples to Elucidate the Immunopathogenesis of Type 1 Diabetes Using the QuPath Software
por: Apaolaza, Paola S., et al.
Publicado: (2021)

Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned
por: Li, Gerald, et al.
Publicado: (2017)

Comparative Analysis of Immunohistochemical Staining Intensity Determined by Light Microscopy, ImageJ and QuPath in Placental Hofbauer Cells
por: Cizkova, Katerina, et al.
Publicado: (2021)

Optimal settings and clinical validation for automated Ki67 calculation in neuroendocrine tumors with open source informatics (QuPath)
por: Pai, Rima, et al.
Publicado: (2022)

Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment
por: Buckley, Niamh E., et al.
Publicado: (2016)

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer
por: Dunne, Philip D., et al.
Publicado: (2016)

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer
por: Dunne, Philip D., et al.
Publicado: (2018)

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015)

Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study
por: Gray, Ronan T, et al.
Publicado: (2017)

Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data
por: McArt, Darragh G., et al.
Publicado: (2013)

Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis
por: de Ruiter, Emma J., et al.
Publicado: (2022)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

Automated tumor analysis for molecular profiling in lung cancer
por: Hamilton, Peter W., et al.
Publicado: (2015)

Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
por: Craig, Stephanie G., et al.
Publicado: (2020)

Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing
por: Scheel, Andreas H., et al.
Publicado: (2023)

Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023)

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study
por: Gray, Ronan T, et al.
Publicado: (2017)

Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
por: Alvi, Muhammad A., et al.
Publicado: (2015)

NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods
por: Roddy, Aideen C, et al.
Publicado: (2019)

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
por: O’Reilly, Paul G., et al.
Publicado: (2016)

Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021)

Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis
por: McCourt, Clare M., et al.
Publicado: (2013)

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer
por: Bradley, Conor A., et al.
Publicado: (2016)

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
por: Humphries, Matthew P., et al.
Publicado: (2018)

Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer’s Disease Brain by Autoradiography Using [(18)F]Flotaza, [(125)I]IBETA, [(124/125)I]IPPI and Immunohistochemistry Analysis Using QuPath
por: Mondal, Rommani, et al.
Publicado: (2023)

Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023)

Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
por: Craig, Stephanie G., et al.
Publicado: (2021)

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma
por: Blayney, Jaine K., et al.
Publicado: (2018)

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies
por: Wen, Qing, et al.
Publicado: (2016)

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study
por: McMenamin, Úna C., et al.
Publicado: (2018)

Improving the Diagnostic Accuracy of the PD-L1 Test with Image Analysis and Multiplex Hybridization
por: Humphries, Matthew P., et al.
Publicado: (2020)

PD-L1 Multiplex and Quantitative Image Analysis for Molecular Diagnostics
por: Abdullahi Sidi, Fatima, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kivdpo4q7kjl1bocdeieqbgf3e